{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T12:42:47Z","timestamp":1773751367398,"version":"3.50.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.ando.2015.10.004","type":"journal-article","created":{"date-parts":[[2015,11,19]],"date-time":"2015-11-19T10:16:51Z","timestamp":1447928211000},"page":"694-697","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Insulin antibodies in patients with type 2 diabetic receiving recombinant human insulin injection: A report of 12 cases"],"prefix":"10.1016","volume":"76","author":[{"given":"Xiaolei","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaowen","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuli","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuling","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2015.10.004_bib0085","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2337\/diacare.16.3.155","article-title":"Immunogenicity and allergenic potential of animal and human insulins","volume":"16","author":"Schernthaner","year":"1993","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ando.2015.10.004_bib0090","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2337\/diacare.12.9.641","article-title":"Clinical significance of insulin antibodies in insulin-treated diabetic patients","volume":"12","author":"Van Haeften","year":"1989","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ando.2015.10.004_bib0095","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1210\/er.2007-0002","article-title":"Immunological responses to exogenous insulin","volume":"28","author":"Fineberg","year":"2007","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ando.2015.10.004_bib0100","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF03256379","article-title":"Frequent reoccurrence of hypoglycemia in a type 2 diabetic patient with insulin antibodies","volume":"14","author":"Zhao","year":"2010","journal-title":"Mol Diagn Ther"},{"key":"10.1016\/j.ando.2015.10.004_bib0105","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.diabres.2009.02.007","article-title":"Characteristics of the antibodies of two patients who developed daytime hyperglycemia and morning hypoglycemia because of insulin antibodies","volume":"84","author":"Ishizuka","year":"2009","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.ando.2015.10.004_bib0110","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2337\/diacare.20.1.71","article-title":"Severe antibody-mediated human insulin resistance: successful treatment with the insulin analog lispro. A case report","volume":"20","author":"Lahtela","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ando.2015.10.004_bib0115","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2337\/diab.27.3.307","article-title":"Immunologic insulin resistance","volume":"27","author":"Davidson","year":"1978","journal-title":"Diabetes"},{"key":"10.1016\/j.ando.2015.10.004_bib0120","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/0002-9343(77)90155-3","article-title":"Insulin antibodies in the pathogenesis of insulin allergy and resistance","volume":"63","author":"Witters","year":"1977","journal-title":"Am J Med"},{"key":"10.1016\/j.ando.2015.10.004_bib0125","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00000441-200505000-00007","article-title":"Hypoglycemia and hyperglycemia due to insulin antibodies against therapeutic human insulin: treatment with double filtration plasmapheresis and prednisolone","volume":"329","author":"Koyama","year":"2005","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.ando.2015.10.004_bib0130","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF02820505","article-title":"Insulin antibodies and hypoglycemia in diabetic patients. Can a quantitative analysis of antibody binding predict the risk of hypoglycemia?","volume":"6","author":"Kim","year":"1997","journal-title":"Endocrine"},{"key":"10.1016\/j.ando.2015.10.004_bib0135","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/BF00284452","article-title":"Immunogenicity of recombinant DNA human insulin","volume":"25","author":"Fineberg","year":"1983","journal-title":"Diabetologia"},{"key":"10.1016\/j.ando.2015.10.004_bib0140","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/dmrr.961","article-title":"Circulating insulin antibodies: influence of continuous subcutaneous or intraperitoneal insulin infusion, and impact on glucose control","volume":"25","author":"Radermecker","year":"2009","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.ando.2015.10.004_bib0145","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s12020-012-9721-0","article-title":"Hypoglycemia due to insulin binding antibodies in a patient with insulin-treated type 2 diabetes and Graves\u2019 disease","volume":"43","author":"Wang","year":"2013","journal-title":"Endocrine"},{"key":"10.1016\/j.ando.2015.10.004_bib0150","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0168-8227(03)00105-0","article-title":"Insulin lispro reduces insulin antibodies in a patient with type 2 diabetes with immunological insulin resistance","volume":"61","author":"Asai","year":"2003","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.ando.2015.10.004_bib0155","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2337\/diacare.23.2.157","article-title":"Efficacy and safety of HOE 901 versus NPH insulin in patients with type 1 diabetes. The European tudy roup of HOE 901 in type 1 diabetes","volume":"23","author":"Pieber","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ando.2015.10.004_bib0160","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cca.2014.03.008","article-title":"Development of insulin antibodies and changes in titers over a long-term period in patients with type 2 diabetes","volume":"433","author":"Hattori","year":"2014","journal-title":"Clin Chim Acta"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426615010884?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426615010884?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T22:48:47Z","timestamp":1757717327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426615010884"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0003426615010884"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2015.10.004","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insulin antibodies in patients with type 2 diabetic receiving recombinant human insulin injection: A report of 12 cases","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2015.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}